Friess Associates’s BioTelemetry, Inc. BEAT Stock Holding History

Friess Associates’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-29,989	Closed	-$1.93M	–	159
2018 Q3	$1.93M	Sell	29,989 -41,011	-58%	-$2.29M	0.13%	99
2018 Q2	$3.19M	Buy	+71,000	New	+$2.83M	0.25%	80
2015 Q3	–	Sell	-63,000	Closed	-$594K	–	196
2015 Q2	$594K	Hold	63,000	–	–	0.05%	106
2015 Q1	$558K	Hold	63,000	–	–	0.05%	104
2014 Q4	$632K	Buy	+63,000	New	+$540K	0.05%	95

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Friess Associates's BEAT Position: Q4 2018 in Review

Friess Associates sold out of BioTelemetry, Inc. (BEAT) in Q4 2018, closing a stake of 29,989 shares — an estimated $1.93M sold.

Friess Associates first reported a position in BEAT in Q4 2014 and held it in 5 quarters. The position peaked at $3.19M in Q2 2018. 281 funds tracked by Wall St. Rank hold BEAT as of Q4 2018.

Friess Associates reported no remaining BioTelemetry, Inc. position as of Q4 2018 after selling out during the quarter.
Friess Associates sold 29,989 BioTelemetry, Inc. shares in Q4 2018, an estimated $1.93M.
Friess Associates first reported a position in BioTelemetry, Inc. in Q4 2014 and held it in 5 quarters.
Friess Associates's BioTelemetry, Inc. position peaked at $3.19M in Q2 2018.
281 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2018.

Based on Friess Associates's 13F filing for Q4 2018, filed 14 Feb 2019.